CREATES Act of 2019
Latest action · May 16, 2019 Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 5, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019
This bill generally allows the developer of a drug or biological product, such as a generic or biosimilar version of a drug, to bring a civil action against the license holder of an approved medication if the holder refuses to make available sufficient quantities of the approved medication for the developer's testing. The bill also establishes affirmative defenses to such a civil action.
In addition, the bill authorizes drug manufacturers seeking Food and Drug Administration approval for a generic drug to use alternative methods to develop elements assure safe use of a drug.Cosponsors 68
Members who signed on, in the order they did. Signatures ran from Feb 5, 2019 to May 10, 2019, with 5 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-WV | David B. McKinley | Original | Feb 5, 2019 |
| R-GA | Doug Collins | Original | Feb 5, 2019 |
| R-WI | F. James Sensenbrenner, Jr. | Original | Feb 5, 2019 |
| D-NY | Jerrold Nadler | Original | Feb 5, 2019 |
| D-VT | Peter Welch | Original | Feb 5, 2019 |
| R-NC | Mark Meadows | Feb 11, 2019 | |
| D-IA | Abby Finkenauer | Mar 4, 2019 | |
| D-IL | Daniel Lipinski | Mar 11, 2019 | |
| D-TX | Lloyd Doggett | Mar 11, 2019 | |
| R-WI | Mike Gallagher | Mar 11, 2019 | |
| R-OK | Tom Cole | Mar 11, 2019 | |
| D-MN | Betty McCollum | Mar 18, 2019 | |
| D-IL | Bobby L. Rush | Mar 18, 2019 | |
| D-MI | Debbie Dingell | Mar 26, 2019 | |
| D-NJ | Frank Pallone, Jr. | Mar 26, 2019 |
Actions 15
Everything that happened, newest first.
- May 16, 2019PERMISSION TO FILE SUPPLEMENTAL - Ms. Lofgren asked unanimous consent that Committee on the Judiciary be authorized to file a supplemental report on the bill, H.R. 965. Agreed to without objection.
- May 16, 2019Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
- May 10, 2019Placed on the Union Calendar, Calendar No. 33.
- May 10, 2019Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-55, Part I.
- May 10, 2019Reported by the Committee on Judiciary. H. Rept. 116-55, Part II.
Related bills 7
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 19 | Lower Costs, More Cures Act of 2019 | Related bill | Dec 19, 2019 |
| S 340 | CREATES Act of 2019 | Identical bill | Feb 6, 2019 |
| HR 987 | Strengthening Health Care and Lowering Prescription Drug Costs Act | Related bill | May 20, 2019 |
| HR 1865 | Further Consolidated Appropriations Act, 2020 | Related bill | Dec 20, 2019 |
| S 1895 | Lower Health Care Costs Act | Related bill | Jul 8, 2019 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 2
Each version as it was printed, newest first.
- May 10, 2019Reported in House
- Feb 5, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.